Physician profile
Sheena White
NPI 1134433691
$592.51
in general payments reported to CMS, 2019-2025
12 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.83 · 2022: $72.95 · 2023: $30.25 · 2024: $254 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $186.30 | 2024-2025 | |
| Verrica Pharmaceuticals INC. | $110.54 | 2024 | Ycanth |
| Merck Sharp & Dohme LLC | $60.41 | 2022-2024 | Gardasil 9, Vaxelis, Gardasil |
| Ironshore Pharmaceuticals INC. | $45.38 | 2022-2024 | |
| Neos Therapeutics, LP | $38.05 | 2024 | Adzenys Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $36.70 | 2021 | |
| Supernus Pharmaceuticals, INC. | $34.93 | 2022-2024 | Qelbree |
| Pfizer INC. | $19.23 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $16.79 | 2025 | Neffy |
| Medline Industries LP | $16.59 | 2024 | |
| Sanofi Pasteur INC. | $16.46 | 2023 | |
| Phadia US INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheena White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.